Centessa Pharmaceuticals (CNTA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

CNTA Centessa Pharmaceuticals

Watchlist

17.040
-1.150-6.32%

Close Nov 22 16:00 ET

17.980
+0.940+5.52%

Post 20:01 ET

2.25BMarket Cap-11210P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Insider Sale: Chief Executive Officer of $CNTA (CNTA) Sells 1,671 Shares
Quiver QuantitativeNov 22 17:17 ET
Maximus Reports Weak Earnings, Joins Atkore, PDD Holdings And Other Big Stocks Moving Lower In Thursday's Pre-Market Session
BenzingaNov 21 07:28 ET
Leerink Partners Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Announces Target Price $24
Moomoo NewsNov 20 12:31 ET · Ratings
Centessa Pharmaceuticals Is Maintained at Buy by Guggenheim
Dow JonesNov 15 14:13 ET · Ratings
Guggenheim Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Raises Target Price to $28
Moomoo NewsNov 15 09:31 ET · Ratings
Morgan Stanley Maintains Centessa Pharmaceuticals(CNTA.US) With Buy Rating, Raises Target Price to $27
Moomoo NewsNov 13 08:31 ET · Ratings

Comments

Stock_Drift

Sep 26 05:05

$Centessa Pharmaceuticals (CNTA.US)$

Trytosaveabit

Apr 23 15:37

Update

$Centessa Pharmaceuticals (CNTA.US)$ Press Release: Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
Dow Jones· 15 mins ago
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
BOSTON and LONDON, April 23, 2024 (GLOBE NEWSWIRE) -- Centessa Pharmaceuticals plc (Nasdaq: CNTA), a clinical-stage pharmaceutical company that aims to discover and develop medicines that are transformational for p...

Trytosaveabit

Apr 22 06:10

Update

$Centessa Pharmaceuticals (CNTA.US)$ The FDA Has Cleared Centessa Pharmaceuticals' Investigational New Drug Application To Initiate A Phase 1 First-in-human, Clinical Trial Of ORX750 For Narcolepsy